Nanexa Ab Stock Net Income
NANEXA Stock | 1.56 0.05 3.31% |
Nanexa AB fundamentals help investors to digest information that contributes to Nanexa AB's financial success or failures. It also enables traders to predict the movement of Nanexa Stock. The fundamental analysis module provides a way to measure Nanexa AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanexa AB stock.
Nanexa |
Nanexa AB Company Net Income Analysis
Nanexa AB's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Nanexa AB Net Income | (36 M) |
Most of Nanexa AB's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanexa AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, Nanexa AB reported net income of (36 Million). This is 110.55% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers-Specialty & Generic industry. The net income for all Sweden stocks is 106.3% higher than that of the company.
Nanexa Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanexa AB's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanexa AB could also be used in its relative valuation, which is a method of valuing Nanexa AB by comparing valuation metrics of similar companies.Nanexa AB is currently under evaluation in net income category among its peers.
Nanexa Fundamentals
Return On Equity | -0.39 | |||
Return On Asset | -0.2 | |||
Profit Margin | (2.23) % | |||
Operating Margin | (2.00) % | |||
Current Valuation | 34.48 M | |||
Shares Outstanding | 60.7 M | |||
Shares Owned By Insiders | 40.75 % | |||
Price To Book | 0.68 X | |||
Price To Sales | 3.34 X | |||
Revenue | 2.37 M | |||
Gross Profit | 4.31 M | |||
EBITDA | (28.35 M) | |||
Net Income | (36 M) | |||
Total Debt | 2.57 M | |||
Book Value Per Share | 2.19 X | |||
Cash Flow From Operations | (25.13 M) | |||
Earnings Per Share | (0.98) X | |||
Number Of Employees | 19 | |||
Beta | 0.74 | |||
Market Capitalization | 244 M | |||
Total Asset | 165 M | |||
Z Score | 56.4 | |||
Net Asset | 165 M |
About Nanexa AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanexa AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanexa AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanexa AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Nanexa Stock
Nanexa AB financial ratios help investors to determine whether Nanexa Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanexa with respect to the benefits of owning Nanexa AB security.